Role of the EpCAM (CD326) in prostate cancer metastasis and progression

Author： Ni Jie

ISSN： 0167-7659

Source： Cancer and Metastasis Reviews, Vol.31, Iss.3-4, 2012-12, pp. : 779-791

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The CD44 Isoforms in Prostate Cancer Metastasis and Progression

By Hao Jingli Ni Jie Graham Peter Cozzi Paul Bucci Joseph Kearsley John Li Yong

Cancer Hallmarks, Vol. 1, Iss. 1, 2013-04 ,pp. : 3-14

American Scientific Publishers

Access to resources Recommend Favorite

Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer

By Schmidt Marcus

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 637-646

Springer Publishing Company

Access to resources Recommend Favorite

Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases

By Cimino Ashley

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 701-708

Springer Publishing Company

Access to resources Recommend Favorite

Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer

International Journal of Oncology, Vol. 46, Iss. 4, 2015-01 ,pp. : 1788-1800

Spandidos Publications

Access to resources Recommend Favorite

Role of Eicosanoids in Prostate Cancer Progression

By Nie D.

Cancer and Metastasis Reviews, Vol. 20, Iss. 3-4, 2001-12 ,pp. : 195-206

Springer Publishing Company

Access to resources Recommend Favorite